Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05114356 · ClinicalTrials.gov registry record
Cervical Interbody Fusion Device Patient Registry
A clinical trial, sponsored by Restor3D.
- Terminated
- Registry status
- 73
- Enrollment target
NCT05114356 is a clinical trial that was terminated before completion, run by Restor3D. The registered enrollment target is 73 participants.
The verdict
NCT05114356 was terminated before completion, sponsored by Restor3D.
- TERMINATED
- Registry status
- 73 participants
- Enrollment target
Study Summary
The registry has been designed as a prospective, observational program for patients undergoing anterior cervical discectomy and fusion (ACDF) procedures treated with TIDAL cervical interbody fusion device. The ultimate goal of the study is to aid in the development of treatment pathways and improved patient care. All patients who agree to participate in the registry will sign an informed consent form and subsequently be treated by their surgeon with the device in either an inpatient or outpatient facility.
Interventions
- DEVICE TIDAL Cervical Interbody Fusion implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2021-11-08 |
| Est. Completion | 2024-05-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05114356
The ClinicalTrials.gov registry entry for NCT05114356 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Restor3D, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TIDAL Cervical Interbody Fusion implant is the first listed.
NCT05114356 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05114356 about?
NCT05114356 is a clinical study titled "Cervical Interbody Fusion Device Patient Registry". The registry has been designed as a prospective, observational program for patients undergoing anterior cervical discectomy and fusion (ACDF) procedures treated with TIDAL cervical interbody fusion device. The ultimate goal of the study is to aid in the development of treatment pathways and improved...
What is the current status of trial NCT05114356?
This trial is currently terminated. The enrollment target is 73 participants. The study started on 2021-11-08. Estimated completion is 2024-05-22.
What interventions are being tested in trial NCT05114356?
The interventions under investigation include: TIDAL Cervical Interbody Fusion implant (DEVICE).
Who is sponsoring clinical trial NCT05114356?
This trial is sponsored by Restor3D, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.